‘At risk mental state’ clinics for psychosis – an idea whose time has come – and gone!
暂无分享,去创建一个
[1] T. McGlashan,et al. Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity. , 2002, The American journal of psychiatry.
[2] I. Falloon,et al. Early intervention for first episodes of schizophrenia: a preliminary exploration. , 1992, Psychiatry.
[3] Godfrey D Pearlson,et al. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. , 2003, Schizophrenia bulletin.
[4] Alice Mulè,et al. Treated Incidence of Psychotic Disorders in the Multinational EU-GEI Study , 2017, JAMA psychiatry.
[5] F. Kane,et al. Social networks and support in first-episode psychosis: exploring the role of loneliness and anxiety , 2014, Social Psychiatry and Psychiatric Epidemiology.
[6] J. van os,et al. A critique of the “ultra‐high risk” and “transition” paradigm , 2017, World psychiatry : official journal of the World Psychiatric Association.
[7] J. Rehm,et al. Cannabis legalization with strict regulation, the overall superior policy option for public health , 2015, Clinical pharmacology and therapeutics.
[8] Peter B. Jones,et al. Psychotic experiences and psychotic disorders at age 18 in relation to psychotic experiences at age 12 in a longitudinal population-based cohort study. , 2013, The American journal of psychiatry.
[9] A. Yung,et al. Cannabis use and symptom severity in individuals at ultra high risk for psychosis: a meta‐analysis , 2017, Acta psychiatrica Scandinavica.
[10] Peter B. Jones,et al. Psychotic symptoms in young people without psychotic illness: mechanisms and meaning , 2012, British Journal of Psychiatry.
[11] J. Addington,et al. Early detection of psychosis: finding those at clinical high risk , 2008, Early intervention in psychiatry.
[12] M. Hickman,et al. Association Between Cannabis and Psychosis: Epidemiologic Evidence , 2016, Biological Psychiatry.
[13] P. Mcguire,et al. Outreach and support in South London (OASIS), 2001–2011: Ten years of early diagnosis and treatment for young individuals at high clinical risk for psychosis , 2013, European Psychiatry.
[14] Paola Dazzan,et al. Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study. , 2015, The lancet. Psychiatry.
[15] Peter B. Jones,et al. From early intervention in psychosis to youth mental health reform: a review of the evolution and transformation of mental health services for young people , 2016, Social Psychiatry and Psychiatric Epidemiology.
[16] P. Delespaul,et al. Toward a world consensus on prevention of schizophrenia , 2005, Dialogues in clinical neuroscience.
[17] Reddy Ms. Attenuated psychosis syndrome. , 2014 .
[18] R. Kydd,et al. Early detection and intervention for initial episodes of schizophrenia. , 1996, Schizophrenia bulletin.
[19] Tyrone D. Cannon,et al. Cortisol Levels and Risk for Psychosis: Initial Findings from the North American Prodrome Longitudinal Study , 2013, Biological Psychiatry.
[20] Tyrone D. Cannon,et al. Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. , 2009, Schizophrenia bulletin.
[21] Hok Pan Yuen,et al. Psychosis prediction: 12-month follow up of a high-risk (“prodromal”) group , 2003, Schizophrenia Research.
[22] Tyrone D. Cannon,et al. An Individualized Risk Calculator for Research in Prodromal Psychosis. , 2016, The American journal of psychiatry.
[23] J. van os,et al. Psychosis as a transdiagnostic and extended phenotype in the general population , 2016, World psychiatry : official journal of the World Psychiatric Association.
[24] R. Murray,et al. PAGES_DCNS 46_5.qxd:DCNS#45 , 2010 .
[25] E. Bramon,et al. Insight in individuals with an At Risk Mental State , 2007, Schizophrenia Research.
[26] M. First,et al. The psychosis risk syndrome and its proposed inclusion in the DSM-V: A risk–benefit analysis , 2010, Schizophrenia Research.
[27] P. Mcguire,et al. Outreach and Support in South London (OASIS). Outcomes of non-attenders to a service for people at high risk of psychosis: the case for a more assertive approach to assessment , 2010, Psychological Medicine.
[28] P. McGuire,et al. Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. , 2012, Archives of general psychiatry.
[29] R. Murray,et al. What causes psychosis? An umbrella review of risk and protective factors , 2018, World psychiatry : official journal of the World Psychiatric Association.
[30] A. Yung,et al. Effectiveness of early intervention in psychosis , 2007, Current opinion in psychiatry.
[31] S. Wood,et al. Further examination of the reducing transition rate in ultra high risk for psychosis samples: The possible role of earlier intervention , 2016, Schizophrenia Research.
[32] Tyrone D. Cannon,et al. Psychosis risk screening with the Prodromal Questionnaire — Brief Version (PQ-B) , 2011, Schizophrenia Research.
[33] A. Yung,et al. Declining transition rates to psychosis: the contribution of potential changes in referral pathways to an ultra–high‐risk service , 2015, Early intervention in psychiatry.
[34] M. Pruessner,et al. Outcome in patients converting to psychosis following a treated clinical high risk state , 2018, Early intervention in psychiatry.
[35] A. David. Why we need more debate on whether psychotic symptoms lie on a continuum with normality , 2010, Psychological Medicine.
[36] P. McGuire,et al. Comorbid Depressive and Anxiety Disorders in 509 Individuals With an At-Risk Mental State: Impact on Psychopathology and Transition to Psychosis , 2012, Schizophrenia bulletin.
[37] I. Hickie,et al. Clinical Staging of Psychiatric Disorders: A Heuristic Framework for Choosing Earlier, Safer and more Effective Interventions , 2006, The Australian and New Zealand journal of psychiatry.
[38] A. Yung,et al. Mapping the Onset of Psychosis: The Comprehensive Assessment of At-Risk Mental States , 2005 .
[39] Daniel H. Mathalon,et al. North American Prodrome Longitudinal Study (NAPLS 2): Overview and recruitment , 2012, Schizophrenia Research.
[40] Peter B. Jones,et al. Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trial , 2012, BMJ : British Medical Journal.
[41] J. Talbott. Outreach and Support in South London (OASIS). Outcomes of non-attenders to a service for people at high risk of psychosis: the case for a more assertive approach to assessment , 2012 .
[42] A. Yung,et al. Testing the Ultra High Risk (prodromal) criteria for the prediction of psychosis in a clinical sample of young people , 2006, Schizophrenia Research.
[43] G. Dunn,et al. The Lambeth Early Onset (LEO) Team: randomised controlled trial of the effectiveness of specialised care for early psychosis , 2004, BMJ : British Medical Journal.
[44] T. Bates,et al. Designing youth mental health services for the 21st century: examples from Australia, Ireland and the UK , 2013, British Journal of Psychiatry.
[45] V. Carr. Time to move on? Commentary on the early intervention in psychosis debate , 2012, The Australian and New Zealand journal of psychiatry.
[46] Tyrone D. Cannon,et al. Comorbid diagnoses for youth at clinical high risk of psychosis , 2017, Schizophrenia Research.
[47] A. Bechdolf,et al. Validation of “prodromal” criteria to detect individuals at ultra high risk of psychosis: 2 year follow-up , 2008, Schizophrenia Research.
[48] M. Gaag,et al. COMT Val158Met genotype and cannabis use in people with an At Risk Mental State for psychosis: Exploring Gene x Environment interactions , 2016, Schizophrenia Research.
[49] Rebecca Cassells,et al. Is headspace making a difference to young people's lives? , 2016 .
[50] V. Carr,et al. Utility of risk-status for predicting psychosis and related outcomes: evaluation of a 10-year cohort of presenters to a specialised early psychosis community mental health service , 2017, Psychiatry Research.
[51] M. Nordentoft,et al. Cost-effectiveness of early intervention in first-episode psychosis: economic evaluation of a randomised controlled trial (the OPUS study) , 2013, British Journal of Psychiatry.
[52] R. Murray,et al. Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study , 2011, Molecular Psychiatry.
[53] T. McGlashan. Psychosis treatment prior to psychosis onset: ethical issues , 2001, Schizophrenia Research.
[54] A. David,et al. Psychosis as a continuous phenotype in the general population: the thin line between normality and pathology , 2016, World psychiatry : official journal of the World Psychiatric Association.
[55] M. Reddy. Attenuated Psychosis Syndrome , 2014, Indian journal of psychological medicine.
[56] R. Murray,et al. Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis. , 2016, Schizophrenia bulletin.
[57] R. Bentall,et al. More harm than good: The case against using antipsychotic drugs to prevent severe mental illness , 2002 .
[58] A. Malla,et al. Is the Clinical High-Risk State a Valid Concept? Retrospective Examination in a First-Episode Psychosis Sample. , 2017, Psychiatric services.
[59] R. Murray,et al. Only a small proportion of patients with first episode psychosis come via prodromal services: a retrospective survey of a large UK mental health programme , 2017, BMC Psychiatry.
[60] R. Murray,et al. Clinical and social determinants of duration of untreated psychosis in the AESOP first-episode psychosis study. , 2006, The British journal of psychiatry : the journal of mental science.
[61] J. Os,et al. An updated and conservative systematic review and meta-analysis of epidemiological evidence on psychotic experiences in children and adults: on the pathway from proneness to persistence to dimensional expression across mental disorders , 2012, Psychological Medicine.
[62] R. Murray,et al. Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users. , 2014, Schizophrenia bulletin.
[63] G C Patton,et al. Monitoring and care of young people at incipient risk of psychosis. , 1996, Schizophrenia bulletin.
[64] R. Murray,et al. Can we identify and treat “schizophrenia light” to prevent true psychotic illness? , 2013, BMJ.
[65] P. McGuire,et al. Duration of untreated psychosis and need for admission in patients who engage with mental health services in the prodromal phase , 2015, British Journal of Psychiatry.
[66] D. Castle. Is it appropriate to treat people at high‐risk of psychosis before first onset? ‐ No , 2012, The Medical journal of Australia.
[67] S. Wood,et al. Neuroimaging Findings in the At-Risk Mental State: A Review of Recent Literature , 2013, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[68] C. Carter,et al. Personalized Prediction of Psychosis: External Validation of the NAPLS-2 Psychosis Risk Calculator With the EDIPPP Project. , 2016, The American journal of psychiatry.
[69] H. Quigley,et al. Traditional marijuana, high‐potency cannabis and synthetic cannabinoids: increasing risk for psychosis , 2016, World psychiatry : official journal of the World Psychiatric Association.
[70] Tyrone D. Cannon,et al. Association of Thalamic Dysconnectivity and Conversion to Psychosis in Youth and Young Adults at Elevated Clinical Risk. , 2015, JAMA psychiatry.
[71] Robin M. Murray,et al. The Epidemiology of Schizophrenia , 2004 .
[72] M. Cannon,et al. Identification and characterization of prodromal risk syndromes in young adolescents in the community: a population-based clinical interview study. , 2012, Schizophrenia bulletin.
[73] Tyrone D. Cannon,et al. Progressive Reduction in Cortical Thickness as Psychosis Develops: A Multisite Longitudinal Neuroimaging Study of Youth at Elevated Clinical Risk , 2015, Biological Psychiatry.